Cargando…
Validation of the (CSR)FENCE score for prediction of febrile neutropenia during chemotherapy cycles 2–6
PURPOSE: Though febrile neutropenia (FN) risk prediction models are important in clinical practice, their external validation is limited. In this study, we validated the Cycle-Specific Risk of FEbrile Neutropenia after ChEmotherapy ((CSR)FENCE) score for predicting FN. METHODS: We reviewed the medic...
Autores principales: | Zatarah, Razan, Faqeer, Nour, Mahmoud, Aseel, Quraan, Tasnim, Matalka, Lujain, Kamal, Aya, Nazer, Lama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576834/ https://www.ncbi.nlm.nih.gov/pubmed/36251222 http://dx.doi.org/10.1007/s12672-022-00575-1 |
Ejemplares similares
-
Validation of the FENCE Risk Groups for Prediction of Febrile Neutropenia With First-Cycle Chemotherapy
por: Zatarah, Razan, et al.
Publicado: (2022) -
1549. Development and Validation of a Cycle-Specific Risk Score for Febrile Neutropenia After Chemotherapy in Patients with Cancer: The (CSR)FENCE Score
por: Aagaard, Theis, et al.
Publicado: (2018) -
Development and Validation of a Risk Score for Febrile Neutropenia After Chemotherapy in Patients With Cancer: The FENCE Score
por: Aagaard, Theis, et al.
Publicado: (2018) -
Prevalence and Predictors of Multi-Drug Resistant Organisms Among Ambulatory Cancer Patients with Urinary Tract Infections
por: AbuSara, Aseel, et al.
Publicado: (2023) -
The reliability of FEbrile Neutropenia after ChEmotherapy (FENCE) scores in predicting granulocyte colony-stimulating factor breakthrough febrile neutropenia among patients with lymphoma undergoing first-cycle chemotherapy: A prospective observational study
por: Thungthong, Pravinwan, et al.
Publicado: (2023)